Open menu

CGM Brand Information

This page lists highlights of Continuous Glucose Monitoring (CGM) Brands and links to more brand resources. Please visit our Continuous Glucose Monitoring page for a full list of our CGM webpages. 

Hypoglycemia and hydroxyurea (Hydrea™, Apo-Hydroxyurea™, Mylan-Hydroxyurea™* hydroxycarbamide):  Medications with hydroxyurea could result in falsely elevated sensor glucose readings in Medtronic and Dexcom sensors (2021). Not Libre. see here)

Alberta covers CGM for all AB patients on basal-bolus insulin, through Blue Cross non-group coverage [Application form: Blue Cross Non-group coverage Application]. Coverage information for Albertans is published online in the Continuous glucose monitor coverage for Albertans Fact Sheet and Coverage Maximums for Diabetes Supplies Fact Sheet. 

  • Patients must be resident of AB, have diabetes, be on basal-bolus insulin (includes patients on pump or pre-mixed insulin)
  • Dexcom and Libre covered. Medtronic CGM available by special authorization. Form is here.
  • A prescription is required.

Be aware that there is a delay in compatibility with new Smart Phone operating system updates. Patients should check company websites to learn which operating systems are compatible with devices.

Abbott's Freestyle Libre 2


PRODUCT SUMMARY: LIBRE

  • 14 day duration. Sensor and transmitter all in one. 
  • Real-time continuous glucose sensor when using using with an upgraded app. Otherwise, it is a flash glucose sensor that needs to be scanned by the phone (or external receiver obtained through Abbott).  
  • Healthcare providers can call 1-800-485-3996 if questions or contact  
  • No calibration is required (eg. no finger stick). Capillary glucose testing is required in some cases as outlined in the product manual. 
  • Encourage patients review  Abbott's Sensor Adhesion Guide. 

REPORTS: LIBRE

TRAINING: LIBRE

WEBSITE & CONTACTS: LIBRE

 


Dexcom 

DEXCOM G7- SUMMARY

Dexcom offers people with diabetes, and on diabetes, the ability to request a Dexcom G7 trial: https://www.dexcom.com/en-ca/interstitial

  • Dexcom G7 is a real-time CGM with alerts and alarms and a built in transmitter
  • 10.5 day wear
  • 30-minute warm-up. Time counts down internally in the sensor. Users can leave the current almost-ended sensor in and running; insert new sensor; end old sensor 25 minutes later and just wait 5 minutes for new sensor to start on the app.
  • MARD 8.2% overall for adults
  • Indicated in pregnancy
  • Alert changes: “delay first high alert”, “silence all alerts” (up to 6 hr)
  • A receiver is available for purchase if the person has no compatible smart phone.
  • Unless indicated for exceptions, no confirmatory capillary glucose test is required prior to bolusing.
  • Not indicated in hemodialysis.
  • Patient instructions for connecting to DCC Clinic Account

DEXCOM G6 - SUMMARY

  • Dexcom G6 is an rtCGM and can provide automated alarms and alerts for low or high gluocse readings or rate changes. 
  • A transmitter (112 day use) is attached to the sensor (10 day use with G6) and wirelessly sends results to a smart phone app or a separately purchased receiver.
  • The screen of the app or receiver shows current glucose level, a trend arrow (if glucose is trending up or down) and graphs for numerous hours previous data.
  • Unless indicated for exceptions, no confirmatory capillary glucose test is required prior to bolusing.
  • Not indicated in hemodialysis.

REPORTS & EDUCATION: DEXCOM

COST ASSISTANCE

Dexcom G7 Patient Benefit Program will will cover 20% of the cost with printed or digital certificates presented to the pharmacist. Provide coupon to patient: DEXCOM_G7_TearSheet_v1r6_ROC 

WEBSITE & CONTACTS DEXCOM

  

 

To view a list of all our CGM pages, please visit our main page, Glucose Sensors and Continuous Glucose Monitors (CGM),